Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysisThi Lien-Anh Nguyên, John Hiscott, Meztli Arguello et al.|Proceedings of the National Academy of Sciences|2008Cited by 182